We are live on ! Find out more

2,057 hedge funds and large institutions have $142B invested in Merck in 2018 Q3 according to their latest regulatory filings, with 117 funds opening new positions, 756 increasing their positions, 900 reducing their positions, and 61 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% more first-time investments, than exits

New positions opened: 117 | Existing positions closed: 61

25% more call options, than puts

Call options by funds: $1.4B | Put options by funds: $1.12B

24% more funds holding in top 10

Funds holding in top 10: 115143 (+28)

18% more capital invested

Capital invested by funds: $120B → $142B (+$21.5B)

2% more funds holding

Funds holding: 2,0182,057 (+39)

1.27% more ownership

Funds ownership: 77.38%78.66% (+1.3%)

16% less repeat investments, than reductions

Existing positions increased: 756 | Existing positions reduced: 900

Holders
2,057
Holders Change
+39
Holders Change %
+1.93%
% of All Funds
47.02%
Holding in Top 10
143
Holding in Top 10 Change
+28
Holding in Top 10 Change %
+24.35%
% of All Funds
3.27%
New
117
Increased
756
Reduced
900
Closed
61
Calls
$1.4B
Puts
$1.12B
Net Calls
+$284M
Net Calls Change
+$173M
Name Holding Trade Value Shares
Change
Change in
Stake
BCIM
201
British Columbia Investment Management
British Columbia, Canada
$69.8M -$20.6M -323,128 -24%
Los Angeles Capital Management
202
Los Angeles Capital Management
California
$69.1M +$16.7M +261,969 +35%
AIA
203
Avalon Investment & Advisory
Texas
$65.6M +$1.16M +18,219 +2%
GIBU
204
Gulf International Bank (UK)
United Kingdom
$65.1M +$3.22M +50,570 +6%
Natixis Advisors
205
Natixis Advisors
Massachusetts
$64.1M +$3M +47,149 +5%
State of Tennessee, Department of Treasury
206
State of Tennessee, Department of Treasury
Tennessee
$63.6M -$29.2M -457,674 -33%
KBG
207
Kahn Brothers Group
New York
$62.9M -$690K -10,833 -1%
EDRH
208
Edmond de Rothschild Holding
Switzerland
$61.7M -$2.64M -41,435 -4%
Mirae Asset Global Investments
209
Mirae Asset Global Investments
South Korea
$61.2M +$49.4M +775,240 +602%
Calamos Advisors
210
Calamos Advisors
Illinois
$60.8M -$631K -9,908 -1%
SOMRS
211
State of Michigan Retirement System
Michigan
$59M -$274K -4,297 -0.5%
Acadian Asset Management
212
Acadian Asset Management
Massachusetts
$58.4M +$7.59M +119,145 +16%
BCM
213
Becker Capital Management
Oregon
$57.2M -$190K -2,986 -0.4%
OAG
214
Orbis Allan Gray
Bermuda
$56.1M +$2.68M +42,054 +5%
LCP
215
LGT Capital Partners
Switzerland
$55.9M -$7.34M -115,287 -12%
GF
216
Gabelli Funds
New York
$55.8M -$327K -5,136 -0.6%
SFM
217
Sphera Funds Management
Israel
$55.3M +$6.68M +104,800 +15%
UIM
218
USS Investment Management
United Kingdom
$54.9M
MIM
219
MetLife Investment Management
New Jersey
$54.9M -$1.22M -19,167 -2%
CAM
220
Cacti Asset Management
Georgia
$54.9M +$138K +2,168 +0.3%
SEI Investments
221
SEI Investments
Pennsylvania
$54.8M -$16.7M -262,664 -24%
BNP Paribas Asset Management
222
BNP Paribas Asset Management
France
$54.4M +$1.41M +22,068 +3%
APG Asset Management
223
APG Asset Management
Netherlands
$54.4M +$174K +2,725 +0.3%
CAM
224
ClariVest Asset Management
California
$54.2M -$3.61M -56,688 -7%
CI
225
Conning Inc
Connecticut
$53.4M -$5.5M -86,276 -10%

MRK Hedge Fund Activity: Q3 2018 in Review

2,057 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2018, worth a combined $142B — up 18% from $120B a quarter earlier.

Buyers outnumbered sellers: 117 funds opened new MRK positions and 61 closed out — a net gain of 56 holders — while 756 added to existing stakes and 900 trimmed.

The largest buyer was Capital International Investors, adding an estimated $1.41B. The largest seller was Capital World Investors, cutting an estimated $1.18B.

  • 2,057 institutional investors held Merck (MRK) as of Q3 2018, up from 2,018 in Q2 2018.
  • Funds reported $142B of Merck stock for Q3 2018, up 18% quarter-over-quarter.
  • 117 funds opened new Merck positions in Q3 2018 and 61 closed out, a net change of +56 holders.
  • The largest Merck buyer in Q3 2018 was Capital International Investors, an estimated $1.41B added.
  • The largest Merck seller in Q3 2018 was Capital World Investors, an estimated $1.18B sold.

Based on aggregated 13F filings for Q3 2018.